Since the publication of the data regarding cyclic dosing from St. George’s University by Liu, et. al in 2016 the question of continuous dosing of LDN versus cyclic dosing has been posed. In this presentation Dr. Anderson will discuss the cell and tumor biology – pharmacology interface where this idea comes from and develop the …
#67 Immunology Part-4 Natural Immunologic Agents CE 2.0 Total | 2.0 of which are Pharm The plethora of new data regarding some natural immunologic agents is seemingly never ending. In this course we will specifically look at current data, testing and assessment and clinical factors in the use of common immunologic natural agents.
#28 Immunology Part-1 Low Dose Naltrexone CE 1.5 Total | 1.5 of which are Pharm Overview: Basic pharmacology of Naltrexone Low versus High Dose Strategies Low Dose Mechanisms Clinical Uses Prescribing Guidelines Resources
#52 NEURO Part-4 Neurological Autoimmunity – Part 2 of 2 CE 1.5 Total | 1.0 of which are Pharm In this two-part webinar Dr. Anderson will break down neurological autoimmunity showing common and unique causes between un-diagnosable (global) neuro-inflammation, Parkinson’s, Alzheimers, MS, ALS and others. A look at assessment, repair strategies and real world potential …
#52 NEURO Part-4 Neurological Autoimmunity – Part 2 of 2 Read More »
